Literature DB >> 18768864

Inside-out regulation of Fc alpha RI (CD89) depends on PP2A.

Jantine E Bakema1, Annie Bakker, Simone de Haij, Henk Honing, Madelon Bracke, Leo Koenderman, Gestur Vidarsson, Jan G J van de Winkel, Jeanette H W Leusen.   

Abstract

To achieve a correct cellular immune response toward pathogens, interaction between FcR and their ligands must be regulated. The Fc receptor for IgA, FcalphaRI, is pivotal for the inflammatory responses against IgA-opsonized pathogens. Cytokine-induced inside-out signaling through the intracellular FcalphaRI tail is important for FcalphaRI-IgA binding. However, the underlying molecular mechanism governing this process is not well understood. In this study, we report that PP2A can act as a molecular switch in FcalphaRI activation. PP2A binds to the intracellular tail of FcalphaRI and, upon cytokine stimulation, PP2A becomes activated. Subsequently, FcalphaRI is dephosphorylated on intracellular Serine 263, which we could link to receptor activation. PP2A inhibition, in contrast, decreased FcalphaRI ligand binding capacity in transfected cells but also in eosinophils and monocytes. Interestingly, PP2A activity was found crucial for IgA-mediated binding and phagocytosis of Neisseria meningitidis. The present findings demonstrate PP2A involvement as a molecular mechanism for FcalphaRI ligand binding regulation, a key step in initiating an immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768864     DOI: 10.4049/jimmunol.181.6.4080

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.

Authors:  Andrew W Gibson; Xinrui Li; Jianming Wu; Julie G Baskin; Chander Raman; Jeffrey C Edberg; Robert P Kimberly
Journal:  J Leukoc Biol       Date:  2011-10-14       Impact factor: 4.962

Review 2.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

3.  Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.

Authors:  Stefan Lohse; Christina Brunke; Stefanie Derer; Matthias Peipp; Peter Boross; Christian Kellner; Thomas Beyer; Michael Dechant; Jan G J van der Winkel; Jeanette H W Leusen; Thomas Valerius
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

4.  Unique ligand-binding property of the human IgM Fc receptor.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; John F Kearney; Hiromi Kubagawa
Journal:  J Immunol       Date:  2015-01-19       Impact factor: 5.422

5.  A monomeric chicken IgY receptor binds IgY with 2:1 stoichiometry.

Authors:  Alexander I Taylor; Rebecca L Beavil; Brian J Sutton; Rosaleen A Calvert
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

6.  BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.

Authors:  Dingfang Liang; Qingyu Zeng; Zhigang Xu; Hai Zhang; Lin Gui; Chong Xu; Sujuan Chen; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Biochem Pharmacol       Date:  2013-11-22       Impact factor: 5.858

7.  Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.

Authors:  Qingyu Zeng; Hai Zhang; Jiamin Qin; Zhigang Xu; Lin Gui; Beibei Liu; Chunxiao Liu; Chong Xu; Wen Liu; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Cell Mol Life Sci       Date:  2015-06-29       Impact factor: 9.207

8.  Antibodies and their receptors: different potential roles in mucosal defense.

Authors:  Rachel E Horton; Gestur Vidarsson
Journal:  Front Immunol       Date:  2013-07-16       Impact factor: 7.561

9.  Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI.

Authors:  Fabian Bohländer; Dennis Riehl; Sabrina Weißmüller; Marcus Gutscher; Jörg Schüttrumpf; Stefanie Faust
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

10.  T cell receptor signaling can directly enhance the avidity of CD28 ligand binding.

Authors:  Mariano Sanchez-Lockhart; Ana V Rojas; Margaret M Fettis; Richard Bauserman; Trissha R Higa; Hongyu Miao; Richard E Waugh; Jim Miller
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.